Brighton Collaboration Vaccine Safety Templates & Benefit-risk assessment Module
Supporting standardized vaccine safety summaries and structured benefit-risk assessment
7:00 AM – 8:00 AM US Eastern Daylight Time (EDT)
Online | Free
Watch the Webinar
Watch the September 24, 2026 SPEAC webinar introducing the Brighton Collaboration Vaccine Safety Templates and Benefit-Risk Assessment Module.
About the Webinar
The Safety Platform for Emergency vACcines (SPEAC), a project of the Coalition for Epidemic Preparedness Innovations (CEPI) and Brighton Collaboration, continues its monthly webinar series showcasing tools and products developed to support vaccine safety monitoring and assessment.
This second session introduces two interrelated tools: the Brighton Collaboration Vaccine Safety Templates , which provide a standardized framework for summarizing key vaccine characteristics, including vaccine safety, immunogenicity, and efficacy data essential to benefit-risk considerations; and the Benefit-Risk Assessment Module , which provides a structured framework to support the planning, conduct, and evaluation of vaccine benefit-risk assessments based on data from clinical trials, post-marketing studies, and real-world evidence.
Each of these tools facilitates objective scientific discourse and informs decision-making among key stakeholders.
What You'll Learn
Explore two complementary resources designed to support vaccine safety evaluation and benefit-risk assessment.
Meet the Tools
Get an introduction to the Brighton Collaboration Vaccine Safety Templates and BRAVATO Benefit-Risk Module.
Support Standardized Assessment
Learn how the tools support standardized vaccine safety summaries and structured benefit-risk assessment.
Explore R&D Applications
Hear expert perspectives on the tools' utility across a variety of vaccine research and development settings.
Ask the Experts
Bring your questions for a live Q&A with the webinar presenters.
Who Will Benefit from the Webinar
Designed for pharmacovigilance professionals, immunization program staff, vaccine safety researchers, manufacturers, regulators, and clinicians involved in vaccine research and development and benefit-risk assessment.
Expert Panel
Perspectives on the tools' utility across a variety of vaccine R&D settings.
Dr. Robert Chen
Brighton Collaboration
USA
Dr. Shelly Karuna
Brighton Collaboration
USA
Dr. Sonali Kochhar
Global Healthcare Consulting
India
Dr. Bennett Levitan
Johnson & Johnson
USA
Dr. Stephen Hadler
The Task Force for Global Health
USA
